Contact Us
Peripheral Arterial Disease Global Market Report 2025
Global Peripheral Arterial Disease Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Peripheral Arterial Disease Global Market Report 2025

By Treatment Type (Devices, Catheters, Drugs, Other Types), By Route of Administration (Oral, Parenteral, Other Route of Administrations), By End User (Hospitals, Specialty Clinics, Others End-Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Peripheral Arterial Disease Market Overview

• Peripheral Arterial Disease market size has reached to $4.36 billion in 2024

• Expected to grow to $6.6 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%

• Growth Driver: Cardiac Disease Prevalence Fuels Growth In The Peripheral Arterial Disease Market

• Market Trend: Innovative Shockwave E8 Peripheral IVL Catheter for Treating Peripheral Arterial Disease

North America was the largest region in 2024.

What Is Covered Under Peripheral Arterial Disease Market?

Peripheral arterial disease (PAD) refers to a medical condition characterized by the narrowing or blockage of the arteries that supply blood to the extremities, typically the legs and feet. It is a type of atherosclerosis, which is an accumulation of fat cells (plaque) in the arteries, leading to reduced blood flow. The treatment of the disease involves a combination of lifestyle modifications, medications and medical procedures aimed at increasing blood supply to the affected extremities, providing symptom relief and lowering the risk of consequences.

The main treatment types for peripheral arterial disease are devices, catheters, drugs and others. Devices for peripheral artery disease (PAD) refer to medical devices that are used for the diagnosis, treatment and management of the condition. The various routes of administration include oral, parenteral and others. These are used by various end-users such as hospitals, specialty clinics and others.

Peripheral Arterial Disease Market Size and growth rate 2025 to 2029: Graph

What Is The Peripheral Arterial Disease Market Size 2025 And Growth Rate?

The peripheral arterial disease market size has grown strongly in recent years. It will grow from $4.36 billion in 2024 to $4.74 billion in 2025 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to innovative medical devices, gene therapy and regenerative medicine, pharmacogenomics, digital health and remote monitoring.

What Is The Peripheral Arterial Disease Market Growth Forecast?

The peripheral arterial disease market size is expected to see strong growth in the next few years. It will grow to $6.6 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to interdisciplinary care teams, minimally invasive interventions, lifestyle and exercise prescriptions. Major trends in the forecast period include vascular tele-rehabilitation, multimodal pain management, wound care advances, public health campaigns.

The forecast of 8.6% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. vascular care by increasing the cost of drug-coated balloons and atherectomy devices sourced from Ireland and Singapore, thereby delaying minimally invasive interventions and elevating cardiology department expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Peripheral Arterial Disease Market Segmented?

1) By Treatment Type: Devices, Catheters, Drugs, Other Types

2) By Route of Administration: Oral, Parenteral, Other Route of Administrations

3) By End User: Hospitals, Specialty Clinics, Others End-Users

Subsegments:

1) By Devices: Stents, Balloons, atherectomy devices

2) By Catheters: Drug-Eluting Catheters, Balloon Catheters, guidewires

3) By Drugs: Antiplatelet Agents, Anticoagulants, Vasodilators

4) By Other Types: Surgical Interventions, Lifestyle Modification Programs, Endovascular Therapy

What Is Driving The Peripheral Arterial Disease Market? Cardiac Disease Prevalence Fuels Growth In The Peripheral Arterial Disease Market

The rising prevalence of cardiac diseases is driving the growth of the peripheral arterial disease market going forward. Cardiac disease is a typical heart disease that impacts the main blood vessels supplying the heart muscle. Peripheral arterial disease treatment helps cardiac patients with improved blood flow, cardiovascular risk reduction, symptom relief and enhanced quality of life. For instance, in December 2023, according to reports published by The Australian Bureau of Statistics (ABS), an Australia-based government agency, in 2022, one in twenty individuals (5.2% or approximately 1.3 million people) were affected by heart, stroke, and vascular diseases. Additionally, in April 2022, according to the American College of Cardiology, a US-based non-profit medical association, the risk factors for ischemic heart disease are predicted to increase by 30.7% to 29 million by 2025. Therefore, the rising prevalence of cardiac diseases drives the peripheral arterial disease industry.

What Is Driving The Peripheral Arterial Disease Market? Growing Prevalence Of Diabetes Is Anticipated To Expand The Peripheral Arterial Diseases

The growing prevalence of diabetes is expected to propel the growth of the peripheral arterial disease market going forward. Diabetes refers to a chronic, metabolic disease characterized by elevated levels of blood glucose (or blood sugar). As the prevalence of diabetes increases, so too does the demand for treatments for this condition. The growing prevalence of diabetes is a factor in peripheral arterial disease (PAD). People with diabetes are at a higher risk of developing atherosclerosis, which is the most common cause of PAD and requires treatment. For instance, in March 2024, according to reports published by The Office for Health Improvement and Disparities (OHID), a UK-based government agency, between the 15 months ending in March 2022 and those ending in March 2023, the percentage of individuals with type 1 diabetes who received eight care processes rose by 22%, while for type 2 diabetes, the increase was 21%. Therefore, the growing prevalence of diabetes is driving the growth of the peripheral arterial disease industry.

Who Are The Major Players In The Global Peripheral Arterial Disease Market?

Major companies operating in the peripheral arterial disease market are Cardinal Health Inc., Johnson and Johnson Limited, Abbott Laboratories, Medtronic PLC, Becton Dickinson and Company, Koninklijke Philips N.V., Boston Scientific Corporation, B. Braun SE, Terumo Corp., Cook Medical LLC, Penumbra Inc., Shockwave Medical Inc., AngioDynamics Inc., Cardiovascular Systems Inc., ACIST Medical Systems Inc., SurModics Inc., Endologix Inc., BioVentrix Inc., QT Vascular Ltd., Avinger Inc., Mercator MedSystems Inc., VentureMed Group Ltd., Eximo Medical Ltd., LimFlow SA, Contego Medical LLC.

What Are The Key Trends Of The Global Peripheral Arterial Disease Market? Innovative Shockwave E8 Peripheral IVL Catheter for Treating Peripheral Arterial Disease

Major companies operating in the peripheral arterial disease market are focused on developing innovative medical devices such as intravascular lithotripsy (IVL) catheter to enhance treatment efficacy, improve patient outcomes, and reduce recovery times for individuals suffering from vascular conditions. Intravascular lithotripsy (IVL) catheter is a medical device used to treat calcified arterial blockages by delivering controlled shockwaves to break down the calcium, helping to restore blood flow and improve vessel flexibility during procedures such as angioplasty. For instance, in September 2024, Shockwave Medical, Inc., a U.S.-based medical technology company, launched the Shockwave E8 peripheral IVL catheter, a medical device designed to treat peripheral arterial disease by delivering targeted intravascular lithotripsy, which uses sonic waves to break down calcium deposits in arterial walls. This innovative approach helps restore blood flow while minimizing trauma to surrounding tissues. The catheter’s advanced design allows for easier navigation through complex vascular anatomy, making IT suitable for a wide range of patients.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Peripheral Arterial Disease Market? Abbott Laboratories Bolsters Cardiovascular Portfolio With Acquisition Of Cardiovascular Systems Inc

In February 2023, Abbott Laboratories, a US-based pharmaceutical company, acquired Cardiovascular Systems Inc. for $890 million. With this acquisition, Abbott aims to strengthen its cardiovascular portfolio and add new complementary technologies. Cardiovascular Systems Inc. is a US-based medical device company that develops and commercializes products for treating peripheral and coronary vascular disease.

Regional Outlook For The Global Peripheral Arterial Disease Market

North America was the largest region in the peripheral artery disease market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Peripheral Arterial Disease Market?

The peripheral artery disease market consists of sales of cardiac medical devices and diagnostic tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Peripheral Arterial Disease Industry?

The peripheral arterial disease market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the peripheral arterial disease industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Peripheral Arterial Disease Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $4.74 billion
Revenue Forecast In 2034 $6.6 billion
Growth Rate CAGR of 8.6% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Treatment Type: Devices, Catheters, Drugs, Other Types
2) By Route of Administration: Oral, Parenteral, Other Route of Administrations
3) By End User: Hospitals, Specialty Clinics, Others End-Users Subsegments: 1) By Devices: Stents, Balloons, Atherectomy Devices
2) By Catheters: Drug-Eluting Catheters, Balloon Catheters, Guidewires
3) By Drugs: Antiplatelet Agents, Anticoagulants, Vasodilators
4) By Other Types: Surgical Interventions, Lifestyle Modification Programs, Endovascular Therapy
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Cardinal Health Inc., Johnson and Johnson Limited, Abbott Laboratories, Medtronic Plc, Becton Dickinson and Company, Koninklijke Philips N.V., Boston Scientific Corporation, B. Braun SE, Terumo Corp., Cook Medical LLC, Penumbra Inc., Shockwave Medical Inc., AngioDynamics Inc., Cardiovascular Systems Inc., ACIST Medical Systems Inc., SurModics Inc., Endologix Inc., BioVentrix Inc., QT Vascular Ltd., Avinger Inc., Mercator MedSystems Inc., VentureMed Group Ltd., Eximo Medical Ltd., LimFlow SA, Contego Medical LLC
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Peripheral Arterial Disease Market Characteristics

3. Peripheral Arterial Disease Market Trends And Strategies

4. Peripheral Arterial Disease Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Peripheral Arterial Disease Growth Analysis And Strategic Analysis Framework

5.1. Global Peripheral Arterial Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Peripheral Arterial Disease Market Growth Rate Analysis

5.4. Global Peripheral Arterial Disease Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Peripheral Arterial Disease Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Peripheral Arterial Disease Total Addressable Market (TAM)

6. Peripheral Arterial Disease Market Segmentation

6.1. Global Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Devices

Catheters

Drugs

Other Types

6.2. Global Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Parenteral

Other Route of Administrations

6.3. Global Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Specialty Clinics

Others End-Users

6.4. Global Peripheral Arterial Disease Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Stents

Balloons

Atherectomy Devices

6.5. Global Peripheral Arterial Disease Market, Sub-Segmentation Of Catheters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Drug-Eluting Catheters

Balloon Catheters

Guidewires

6.6. Global Peripheral Arterial Disease Market, Sub-Segmentation Of Drug, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Antiplatelet Agents

Anticoagulants

Vasodilators

6.7. Global Peripheral Arterial Disease Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Surgical Interventions

Lifestyle Modification Programs

Endovascular Therapy

7. Peripheral Arterial Disease Market Regional And Country Analysis

7.1. Global Peripheral Arterial Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Peripheral Arterial Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Peripheral Arterial Disease Market

8.1. Asia-Pacific Peripheral Arterial Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Peripheral Arterial Disease Market

9.1. China Peripheral Arterial Disease Market Overview

9.2. China Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Peripheral Arterial Disease Market

10.1. India Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Peripheral Arterial Disease Market

11.1. Japan Peripheral Arterial Disease Market Overview

11.2. Japan Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Peripheral Arterial Disease Market

12.1. Australia Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Peripheral Arterial Disease Market

13.1. Indonesia Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Peripheral Arterial Disease Market

14.1. South Korea Peripheral Arterial Disease Market Overview

14.2. South Korea Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Peripheral Arterial Disease Market

15.1. Western Europe Peripheral Arterial Disease Market Overview

15.2. Western Europe Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Peripheral Arterial Disease Market

16.1. UK Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Peripheral Arterial Disease Market

17.1. Germany Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Peripheral Arterial Disease Market

18.1. France Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Peripheral Arterial Disease Market

19.1. Italy Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Peripheral Arterial Disease Market

20.1. Spain Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Peripheral Arterial Disease Market

21.1. Eastern Europe Peripheral Arterial Disease Market Overview

21.2. Eastern Europe Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Peripheral Arterial Disease Market

22.1. Russia Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Peripheral Arterial Disease Market

23.1. North America Peripheral Arterial Disease Market Overview

23.2. North America Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Peripheral Arterial Disease Market

24.1. USA Peripheral Arterial Disease Market Overview

24.2. USA Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Peripheral Arterial Disease Market

25.1. Canada Peripheral Arterial Disease Market Overview

25.2. Canada Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Peripheral Arterial Disease Market

26.1. South America Peripheral Arterial Disease Market Overview

26.2. South America Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Peripheral Arterial Disease Market

27.1. Brazil Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Peripheral Arterial Disease Market

28.1. Middle East Peripheral Arterial Disease Market Overview

28.2. Middle East Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Peripheral Arterial Disease Market

29.1. Africa Peripheral Arterial Disease Market Overview

29.2. Africa Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Peripheral Arterial Disease Market Competitive Landscape And Company Profiles

30.1. Peripheral Arterial Disease Market Competitive Landscape

30.2. Peripheral Arterial Disease Market Company Profiles

30.2.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson and Johnson Limited Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Peripheral Arterial Disease Market Other Major And Innovative Companies

31.1. Koninklijke Philips N.V.

31.2. Boston Scientific Corporation

31.3. B. Braun SE

31.4. Terumo Corp.

31.5. Cook Medical LLC

31.6. Penumbra Inc.

31.7. Shockwave Medical Inc.

31.8. AngioDynamics Inc.

31.9. Cardiovascular Systems Inc.

31.10. ACIST Medical Systems Inc.

31.11. SurModics Inc.

31.12. Endologix Inc.

31.13. BioVentrix Inc.

31.14. QT Vascular Ltd.

31.15. Avinger Inc.

32. Global Peripheral Arterial Disease Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Peripheral Arterial Disease Market

34. Recent Developments In The Peripheral Arterial Disease Market

35. Peripheral Arterial Disease Market High Potential Countries, Segments and Strategies

35.1 Peripheral Arterial Disease Market In 2029 - Countries Offering Most New Opportunities

35.2 Peripheral Arterial Disease Market In 2029 - Segments Offering Most New Opportunities

35.3 Peripheral Arterial Disease Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Peripheral Arterial Disease Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Peripheral Arterial Disease Market, Sub-Segmentation Of Catheters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Peripheral Arterial Disease Market, Sub-Segmentation Of Drug, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Peripheral Arterial Disease Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Peripheral Arterial Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Peripheral Arterial Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Cardinal Health Inc. Financial Performance
  • Table 79: Johnson and Johnson Limited Financial Performance
  • Table 80: Abbott Laboratories Financial Performance
  • Table 81: Medtronic Plc Financial Performance
  • Table 82: Becton Dickinson and Company Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Peripheral Arterial Disease Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Peripheral Arterial Disease Market, Sub-Segmentation Of Catheters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Peripheral Arterial Disease Market, Sub-Segmentation Of Drug, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Peripheral Arterial Disease Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Peripheral Arterial Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Peripheral Arterial Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Cardinal Health Inc. Financial Performance
  • Figure 79: Johnson and Johnson Limited Financial Performance
  • Figure 80: Abbott Laboratories Financial Performance
  • Figure 81: Medtronic Plc Financial Performance
  • Figure 82: Becton Dickinson and Company Financial Performance

Frequently Asked Questions

Peripheral arterial disease (PAD) refers to a medical condition characterized by the narrowing or blockage of the arteries that supply blood to the extremities, typically the legs and feet. It is a type of atherosclerosis, which is an accumulation of fat cells (plaque) in the arteries, leading to reduced blood flow. The treatment of the disease involves a combination of lifestyle modifications, medications and medical procedures aimed at increasing blood supply to the affected extremities, providing symptom relief and lowering the risk of consequences. For further insights on this market, request a sample here

The market major growth driver - Cardiac Disease Prevalence Fuels Growth In The Peripheral Arterial Disease Market. For further insights on this market, request a sample here

The peripheral arterial disease market size has grown strongly in recent years. It will grow from $4.36 billion in 2024 to $4.74 billion in 2025 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to innovative medical devices, gene therapy and regenerative medicine, pharmacogenomics, digital health and remote monitoring. The peripheral arterial disease market size is expected to see strong growth in the next few years. It will grow to " $6.6 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to interdisciplinary care teams, minimally invasive interventions, lifestyle and exercise prescriptions. Major trends in the forecast period include vascular tele-rehabilitation, multimodal pain management, wound care advances, public health campaigns. For further insights on this market, request a sample here

The peripheral arterial diseasemarket covered in this report is segmented –
1) By Treatment Type: Devices; Catheters; Drugs; Other Types
2) By Route of Administration: Oral; Parenteral; Other Route of Administrations
3) By End User: Hospitals; Specialty Clinics; Others End-Users Subsegments:
1) By Devices: Stents; Balloons; Atherectomy Devices
2) By Catheters: Drug-Eluting Catheters; Balloon Catheters; Guidewires
3) By Drugs: Antiplatelet Agents; Anticoagulants; Vasodilators
4) By Other Types: Surgical Interventions; Lifestyle Modification Programs; Endovascular Therapy For further insights on this market,
request a sample here

North America was the largest region in the peripheral artery disease market in 2024. The regions covered in peripheral artery disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on this market, request a sample here.

Major companies operating in the peripheral arterial disease market are Cardinal Health Inc., Johnson and Johnson Limited, Abbott Laboratories, Medtronic PLC, Becton Dickinson and Company, Koninklijke Philips N.V., Boston Scientific Corporation, B. Braun SE, Terumo Corp., Cook Medical LLC, Penumbra Inc., Shockwave Medical Inc., AngioDynamics Inc., Cardiovascular Systems Inc., ACIST Medical Systems Inc., SurModics Inc., Endologix Inc., BioVentrix Inc., QT Vascular Ltd., Avinger Inc., Mercator MedSystems Inc., VentureMed Group Ltd., Eximo Medical Ltd., LimFlow SA, Contego Medical LLC.. For further insights on this market, request a sample here.

Major trends in this market include Innovative Shockwave E8 Peripheral IVL Catheter for Treating Peripheral Arterial Disease. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon